Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$13.18 - $19.41 $302,388 - $445,323
-22,943 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$14.73 - $35.25 $89,352 - $213,826
-6,066 Reduced 20.91%
22,943 $450,000
Q4 2021

Feb 15, 2022

SELL
$33.72 - $48.22 $583,659 - $834,639
-17,309 Reduced 37.37%
29,009 $995,000
Q3 2021

Nov 15, 2021

SELL
$49.26 - $74.5 $2.27 Million - $3.44 Million
-46,145 Reduced 49.91%
46,318 $2.53 Million
Q2 2021

Aug 16, 2021

BUY
$56.91 - $127.53 $5.26 Million - $11.8 Million
92,463 New
92,463 $6.79 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.